Oncotarget

Research Papers: Immunology:

Mycobacterium tuberculosis Rv3628 drives Th1-type T cell immunity via TLR2-mediated activation of dendritic cells and displays vaccine potential against the hyper-virulent Beijing K strain

Woo Sik Kim, Jong-Seok Kim, Seung Bin Cha, Hongmin Kim, Kee Woong Kwon, So Jeong Kim, Seung Jung Han, Soo Young Choi, Sang-Nae Cho, Jong-Hwan Park _ and Sung Jae Shin

PDF  |  HTML  |  Supplementary Files  |  How to cite

Oncotarget. 2016; 7:24962-24982. https://doi.org/10.18632/oncotarget.8771

Metrics: PDF 2635 views  |   HTML 2756 views  |   ?  


Abstract

Woo Sik Kim1,*, Jong-Seok Kim1,*, Seung Bin Cha1, Hongmin Kim1, Kee Woong Kwon1, So Jeong Kim1, Seung Jung Han1, Soo Young Choi1, Sang-Nae Cho1, Jong-Hwan Park2 and Sung Jae Shin1

1 Department of Microbiology, Institute for Immunology and Immunological Diseases, Brain Korea 21 PLUS Project for Medical Science, Yonsei University College of Medicine, Seoul, South Korea

2 Laboratory of Animal Medicine, College of Veterinary Medicine, Chonnam National University, Gwangju, South Korea

* These authors have contributed equally to this work

Correspondence to:

Jong-Hwan Park, email:

Sung Jae Shin, email:

Keywords: tuberculosis; DC maturation; Toll-like receptor 2; multifunctional T cell; subunit vaccine; Immunology and Microbiology Section; Immune response; Immunity

Received: December 07, 2015 Accepted: April 06, 2016 Published: April 16, 2016

Abstract

Identification of vaccine target antigens (Ags) that induce Ag-specific Th1 immunity is the first step toward the development of a tuberculosis vaccine. Here, we evaluated the Mycobacterium tuberculosis (Mtb) protein Rv3628, a soluble inorganic pyrophosphatase, as a vaccine target and characterized the molecular details of its interaction with dendritic cells (DCs). Rv3628 activated DCs, increasing their expression of cell surface molecules and augmenting their production of TNF-α, IL-1β, IL-6, and IL-12p70. Rv3628 mediated these effects by binding to TLR2 and activating downstream MyD88-, MAPK- and NF-κB-dependent signaling pathways. Rv3628-stimulated DCs induced the expansion of OVA-specific CD4+ and CD8+ T cells, which secreted IFN-γ and IL-2. Rv3628-specific effector/memory T cells expanded to a similar extent as those stimulated with ESAT-6 Ag in samples of lung and spleen cells collected from Mtb-infected mice. Finally, an Rv3628 subunit vaccine adjuvanted with dimethyldioctadecylammonium liposomes containing monophosphoryl lipid-A caused significant reductions in bacterial counts and lung inflammation after challenge with the hyper-virulent Mtb K strain. Importantly, protective efficacy was correlated with the generation of Rv3628-specific CD4+ T cells co-producing IFN-γ, TNF-α and IL-2 and exhibiting an elevated IFN-γ recall response. Thus, Rv3628 polarizes DCs toward a Th1 phenotype and promotes protective immunity against Mtb infection.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 8771